BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 15644990)

  • 1. Although antidepressants and anxiolytics are frequently used together to treat depression in the acute phase, how effective is the concomitant use of these drugs?
    Kanba S
    J Psychiatry Neurosci; 2004 Nov; 29(6):485. PubMed ID: 15644990
    [No Abstract]   [Full Text] [Related]  

  • 2. [Coadministration benzodiazepine and antidepressant drugs: the state of art].
    Martin P
    Encephale; 2006 Oct; 32(5 Pt 1):753-66. PubMed ID: 17099600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anxiety and depression: which antidepressants treat both at the same time?].
    Laflamme F
    Perspect Infirm; 2010; 7(2):43. PubMed ID: 21744603
    [No Abstract]   [Full Text] [Related]  

  • 4. Buspirone augmentation of a selective serotonin reuptake inhibitor: efficacy in two depressed patients with comorbid anxiety and type I alcohol dependence.
    Sprenger D
    J Clin Psychopharmacol; 1997 Oct; 17(5):425-6. PubMed ID: 9315996
    [No Abstract]   [Full Text] [Related]  

  • 5. Chronic treatment with tandospirone, a serotonin 1A receptor partial agonist, inhibits psychosocial stress-induced changes in hippocampal neurogenesis and behavior.
    Murata Y; Yanagihara Y; Mori M; Mine K; Enjoji M
    J Affect Disord; 2015 Jul; 180():1-9. PubMed ID: 25879718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of tandospirone augmentation in major depressive disorder patients with high anxiety: A multicenter, randomized, parallel-controlled, open-label study.
    Lin J; Su Y; Wang C; Yang F; Xu Y; Yuan Y; Yuan Y; Wang X; Yu X; Si T
    J Psychiatr Res; 2018 Apr; 99():104-110. PubMed ID: 29433063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapy of generalized anxiety disorder.
    Davidson JR
    J Clin Psychiatry; 2001; 62 Suppl 11():46-50; discussion 51-2. PubMed ID: 11414551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New developments in the neurobiological basis of anxiety disorders.
    Gorman JM; Hirschfeld RM; Ninan PT
    Psychopharmacol Bull; 2002; 36 Suppl 2():49-67. PubMed ID: 12490823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible mild serotonin syndrome related to co-prescription of tandospirone and trazodone.
    Kaneda Y; Ohmori T; Okabe H
    Gen Hosp Psychiatry; 2001; 23(2):98-101. PubMed ID: 11354048
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacology of anxiolytics and their therapeutic use].
    Tada K
    Ryoikibetsu Shokogun Shirizu; 2003; (38):608-11. PubMed ID: 12877061
    [No Abstract]   [Full Text] [Related]  

  • 11. [Mood disorders].
    Passerieux C; Hardy-Baylé MC
    Rev Prat; 2008 Oct; 58(16):1809-14. PubMed ID: 19143154
    [No Abstract]   [Full Text] [Related]  

  • 12. Treating comorbid depression and anxiety.
    Kuzel RJ
    J Fam Pract; 1996 Dec; 43(6 Suppl):S45-53. PubMed ID: 8969712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview and treatment of social anxiety disorder.
    Raj A
    Manag Care; 2004 Jun; 13(6 Suppl Depression):52-7. PubMed ID: 15293772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How to manage anxious patients who are depressed.
    Sussman N
    J Clin Psychiatry; 1993 May; 54 Suppl():8-16; discussion 17-20. PubMed ID: 8099581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why settle for silver, when you can go for gold? Response vs. recovery as the goal of antidepressant therapy.
    Stahl SM
    J Clin Psychiatry; 1999 Apr; 60(4):213-4. PubMed ID: 10221279
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical efficacy of tandospirone augmentation in patients with major depressive disorder: a randomized controlled trial.
    Yamada K; Yagi G; Kanba S
    Psychiatry Clin Neurosci; 2003 Apr; 57(2):183-7. PubMed ID: 12667165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of new antidepressants in the treatment of anxiety/depressive disorders.
    Boerner RJ; Möller HJ
    Pharmacopsychiatry; 1999 Jul; 32(4):119-26. PubMed ID: 10505481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic treatments effective in both generalized anxiety disorder and major depressive disorder: clinical and theoretical implications.
    Casacalenda N; Boulenger JP
    Can J Psychiatry; 1998 Sep; 43(7):722-30. PubMed ID: 9773222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use and development of anxiolytics in Japan.
    Yamawaki S
    Eur Neuropsychopharmacol; 1999 Dec; 9 Suppl 6():S413-9. PubMed ID: 10622688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comorbid anxiety and depression.
    Pollack MH
    J Clin Psychiatry; 2005; 66 Suppl 8():22-9. PubMed ID: 16336033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.